Mcdermott Health Podcast Channel

In this episode, host Brian Fortune, senior managing director at Farragut Square Group (FSG), is joined by FSG’s own Assistant Vice President, Holly Stokes, in an insightful overview of the recently released 2024 Physician Fee Schedule (PFS) proposed rule. They shed light on the PFS’s significance and impact on providers. Holly provides a comprehensive overview of the proposed changes, including the notable 3.4% cut to the conversion factor, and presents an outlook for potential congressional intervention as well as other specialty-specific changes.

In this episode, host Brian Fortune, senior managing director at Farragut Square Group, is joined by L.A. Galyon IV, managing partner at Brentwood Capital Advisors, for the final segment of our three-part behavioral health series. Together, they have a riveting conversation on the psychiatry space, discussing today’s macro-environment and service mix. Additionally, they provide insights on current reimbursement issues and investment opportunities within the sector.

During this episode, host Brian Fortune, senior managing director at Farragut Square Group, is joined by L.A. Galyon IV, managing partner at Brentwood Capital Advisors, for part two in our three-part behavioral health series. Together, they delve into the substance use disorder (SUD) space and its macro environment. They also share their thoughts on the evolving demand for relevant services in recent years and provide valuable insights on investment opportunities within the SUD sector.

In this episode, host Brian Fortune, senior managing director at Farragut Square Group, is joined by Dan Beuerlein, managing director at Brentwood Capital Advisors. Embarking on a three-part behavioral health series, Brian and Dan discuss the autism space, including the macro environment for autism, as well as the service mix and evolution. They also share their thoughts on investing in the autism space.  

In this episode, hosts Kristian Werling, McDermott partner and co-head of the Firm’s Private Equity Practice Group and Brian Fortune, senior managing director at Farragut Square Group, recap McDermott’s 2023 HPE Miami event. Together, they share key themes from the conference, discuss current healthcare deal market highlights and chat about various areas of interest and activity in spaces such as infusion/AICs, cardiology, ophthalmology, home care personal services, payor services, etc. Brian and Krist also share their thoughts on the timing of market activity and Silicon Valley Bank’s impact on the market.

In this episode, host Brian Fortune, senior managing director at Farragut Square Group, and Krist Werling, McDermott partner and co-head of the Private Equity Practice Group, are joined by Brown Gibbons Lang & Company’s own John M. Tiedmann Jr., Director and senior member, and J. Kyle Brown, Managing Director and senior member of their Healthcare & Life Sciences team. They discuss the current state of the deal market and deal flow and provide insight into the most active spaces in healthcare and the macro market forces affecting opportunities this year.

In the 14th episode of Season 2: Driving the Deal, Krist Werling, McDermott Will & Emery partner and co-head of the Firm’s private equity practice, and Brian Fortune, senior managing director at Farragut Square Group, recap McDermott’s 2022 HPE New York event. Together, they share key themes from the conference and discuss current healthcare deal market highlights, including: The trends slowing down large deals while also powering activity in the low and middle market The current debt market, outlook for 2023 and potential financing opportunities A look at the activity within the pharmaceutical services space An overview of recent CMS rulemaking (e., PFS, OPPS, home health and ESRD)  The future of dealmaking as we head toward a potential recession

The board’s executive compensation committee is the focus point for many of the extraordinary financial, economic and operating challenges currently facing healthcare organizations. Executive compensation increases are impacted by both an inflationary economy and significant revenue downturn. In addition, the Department of Justice has identified executive compensation as an important conduit through by which corporate compliance incentives and deterrence can be implemented. Furthermore, executive recruitment and retention amidst the “Great Resignation” remains a key compensation concern.   These and similar issues have become important agenda items for the board’s executive compensation Committee. Michael Peregrine is joined by industry experts Tim Cotter and Ralph DeJong for the first in a two-part conversation about the impact of the developments on the compensation committee, including:   Key topics for briefing the board’s compensation committee. Increasing communication between the compensatio

Nonprofit healthcare organizations and their governing boards are subject to the authority of the state attorney general, which has broad statutory and common law power with respect to its duty to preserve charitable assets. The attorney general is supported in this work by dedicated charity officials who work within what is normally referred to as the “charitable trust division” of the attorney general’s office.   To help inform nonprofit health systems and their leaders on the role of the attorney general and its charity regulators, Michael Peregrine is joined by Leslie Friedlander, an Assistant Attorney General in the office of the Texas Attorney General. Leslie is currently the president of the National Association of State Charity Officials (NASCO), and offers a “refresher course” about state regulation of nonprofit organizations, and NASCO’s related educational role, including: An overview of the role of NASCO, its purposes, and the value of its educational materials. Charity officials’ inter

Corporate directorship continues relentlessly to increase in complexity. The ability of directors to fully engage with the board agenda and to be effective partners in management are two of the most critical corporate governance issues in the current environment. These are issues that implicate a level of commitment by directors to be informed, attentive, and up to speed on their duties and on the issues of importance to the organization that they serve. This commitment is made even more critical this year by the many turns of events that are impacting the agenda in many boardrooms.   To learn more about how directors at leading companies are handling this increase in role complexity board communication, Kimberly Simpson, the COO of NACD (the National Association of Corporate Directors) which serves both for-profit and nonprofit directors and boards, and offers the country’s premier director certification program, joins Michael Peregrine for a conversation about the multifactorial challenges facing

In Season 2, Episode 13 of Driving the Deal, Farragut Square Group’s (FSG) Brian Fortune and Jackie Williams are joined by FSG’s Assistant Vice President Hope Amsterdam. In this episode, they discuss recent reimbursement-related developments for Medicare and Medicaid on the state level, as well as: Major Medicare and Medicaid investments made by states during the most recent budget cycle Positive July rulemaking for post-acute care and inpatient psychology Reimbursement adjustments for hospice, inpatient rehabilitation facilities and inpatient psychology Case-mix adjustments to the positive skilled nursing facility (SNF) patient-driven payment model Centers for Medicare & Medicaid Services’ (CMS) final rule for SNFs Home Health proposed "Temporary” and “Permanent” adjustments

In the 12th episode of Season 2: Driving the Deal, Farragut Square Group’s (FSG) Brian Fortune and Jackie Williams are joined by Holly Stokes, senior research associate at FSG, for a discussion on the future of physician practice management (PPM). Specifically, the trio delves into the regulatory actions that occurred within the PPM sector this past year as we head into end-of-year legislation and rulemaking, as well as the anticipated pressures for market participants in 2023 and 2024. In this episode, they also talk about: Regulatory changes for PPM companies Proposed cuts to the Physician Fee Schedule Implications of the ruling in Dobbs v. Jackson Women’s Health Organization on the fertility and OBGYN sectors Drug pricing provisions in the Inflation Reduction Act of 2022 Future implementation of the No Surprises Act and qualifying payment amount calculation

In the 11th episode of Season 2: Driving the Deal, Krist Werling, McDermott partner and co-head of the Private Equity Practice Group, and Brian Fortune, senior managing director at Farragut Square Group, are joined for a guest interview hosted by Farragut Square Group’s own Jackie Williams and Hope Amsterdam. In this episode, Hope and Jackie interview Damon Terzaghi, senior director of LTSS policy at the National Association of States United for Aging and Disabilities, to provide an overview of the home- and community-based services (HCBS) space. Together, they discuss the following:  The increase in demand for HCBS before and after COVID-19 The increased Federal Medical Association Percentages reimbursement for HCBS The likelihood of increased funding to exist beyond the public health emergency Labor issues surrounding the HCBS space Priorities for states surrounding HCBS after the pandemic  

In the 10th episode of Season 2: Driving the Deal, Krist Werling, McDermott partner and co-head of the Private Equity Practice Group, and Brian Fortune, senior managing director at Farragut Square Group, are joined by Mark Francis, managing director at Houlihan Lokey and head of its Healthcare Group, as they summarize the end of Q2 for the healthcare industry. Together, they discuss the following:  Healthcare sectors poised to see an increase in deal volume and activity A review of activity and deal flow in Q1 and Q2 Sectors that are cooling off post-Q1 and Q2 The impact of digital health on the healthcare industry Sectors heading into distress territory Q3 insights

To highlight the important connections between financial risk management, the credit rating process and effective governance, Michael Peregrine welcomes Lisa Goldstein, Senior Vice President at Kauffman Hall and a nationally recognized analyst, speaker, writer and expert on nonprofit healthcare, for a conversation exploring:  The responsibilities of a strong finance committee The value of subject matter expertise within the finance committee Key metrics that rating agencies use to evaluate governance Insights from high-performing healthcare system boards The role of covenant management in repayment performance Lessons learned from the pandemic, including credit-related crisis management ESG issues for nonprofit healthcare  

In the newest episode of Season 2: Driving the Deal, Krist Werling, McDermott partner and co-head of the Private Equity Practice Group, and Brian Fortune, senior managing director at Farragut Square Group, are joined by Ashley Fischer, McDermott health antitrust partner. Together, they discuss the following concerning healthcare antitrust in the Biden administration: The Federal Trade Commission’s (FTC) signaled interest in the effect of private equity on competition How the FTC views hospital consolidation Major cases in the physician market and subsequent enforcement activity Tips for investing with new scrutiny Labor market competition and recent significant cases

In episode 8 of Season 2: Driving the Deal, Brian Fortune, senior managing director at Farragut Square Group (FSG), is joined by Elle Kalisz, a research analyst at FSG, and Swatee Survee, CEO and founder of Litesprite. Together, they explore all things digital technology, including: What is a Digital Therapeutic? What makes a Digital Therapeutic different from traditional digital health tools? The intersection of digital self-help tools and mobile gaming. Provider, payor and employer uptake/participation. Insights for investors interested in the digital technology space.

July 30, 2022, marks the 20th anniversary of the Sarbanes Oxley Act, one of the most consequential pieces of federal financial regulation ever enacted into law. It serves as the foundation for many of the guidelines and principles that are now considered routine by boards and their audit, compensation and finance committees. It’s difficult to overstate the continuing impact of Sarbanes on corporate governance. Thus, given the passage of time there is value in board members refreshing their familiarity with the Sarbanes history, in order to better appreciate its influence.   To help underscore the Sarbanes legacy, Michael Peregrine welcomes back Scott Steffens, well-known audit partner in Grant Thornton’s national nonprofit and educational practice. In their conversation, Scott and Michael review the circumstances that led to Sarbanes’s enactment, and how auditor, management and audit committee interactions have changed over the last 20 years, particularly in the nonprofit and healthcare sectors, inc

In Season 2, Episode 7 of Driving the Deal, Krist Werling, McDermott partner and co-head of the Firm’s Private Equity Practice Group, and Brian Fortune, senior managing director at Farragut Square Group, are joined by Brian Stimson, a partner in McDermott’s Healthcare Practice Group and former Acting General Counsel and Principal Deputy General Counsel for the US Department of Health and Human Services. Together they discuss current litigation surrounding the impending future of the No Surprises Act, as well as: -The specialties most impacted by the legislation and subsequent litigation - An overview of the No Surprises Act and current litigation surrounding it -The Act’s impact on providers -Next steps for future litigation

Recent events have made it clear that the board won’t be retreating any time soon from a high level of engagement with management on patient care and safety matters, but what is the appropriate level of board engagement? To answer that question, welcomes back , president of Orlikoff & Associates, Inc., and , MWE partner, leader of McDermott health advisory on patient care and safety and accreditation issues, and author of the recent client memo series on vaccination mandates and workplace safety developments, for an update on where we stand two years into the COVID-19 pandemic, including:   Implications and expectations from hospital boards regarding current COVID-19 rates. The regulatory authorities response to competing pandemic-related pressures. Board guidance for addressing financial concerns in light of a stealth surge  The governance challenges associated with growing supply chain issues.  Universal truths following the pandemic that are valuable to healthcare boards.  Definin